A restriction endonuclease that recognizes the sequence AT^CG_AT.
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0444872-V3
- Awardee
- New England Biolabs Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $72.80
About this award
New England Biolabs Inc has been awarded contract A207_PO-0444872-V3 by the University of Virginia, effective August 8, 2026. The cumulative contract value is $72.00. The prime contractor will deliver restriction endonuclease enzymes that recognize the AT^CG_AT sequence to the University of Virginia as the buyer.
The contract specifies delivery of 72 units of the restriction endonuclease at a unit price of $1.00 each. The award is issued through the Commonwealth of Virginia contracting process. No specific period of performance beyond the award date or place of performance details beyond the buyer location have been provided in the available documentation.
Line items
| Item | Total |
|---|---|
| A restriction endonuclease that recognizes the sequence AT^CG_AT. | $72.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0444872-V3?
Contract A207_PO-0444872-V3 was awarded to New England Biolabs Inc by University of Virginia on August 8, 2026.
How much is contract A207_PO-0444872-V3 worth?
Its cumulative value is $72.80.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award